Cannabidiol for Lennox-Gastaut: Cannabinoid Clinical Trials
Comments Off on Cannabidiol for Lennox-Gastaut: Cannabinoid Clinical Trials
March 4, 2026
Clinically meaningful reduction in drop seizures has been observed in Lennox-Gastaut syndrome patients treated with cannabidiol. Clinical trials show that even reductions below 50% can improve patient quality of life. Caregiver-reported outcomes align…
Cannabidiol for Lennox-Gastaut: Clinical Trial Evidence and Insights
Comments Off on Cannabidiol for Lennox-Gastaut: Clinical Trial Evidence and Insights
March 3, 2026
Clinically meaningful cannabidiol reduction offers new hope for Lennox-Gastaut syndrome patients by improving drop seizure outcomes. Recent clinical trials demonstrate that even reductions below 50% can be impactful. Caregiver reports support…